Johnson & Johnson gets FDA warning on marketing

Aug 24, 2010 By LINDA A. JOHNSON , AP Business Writer

(AP) -- A Johnson & Johnson business that makes joint replacements has been warned by the Food and Drug Administration that it is illegally marketing two products.

The FDA notified Johnson & Johnson's DePuy Orthopaedics Inc. that it is selling one product that was never approved for sale and is selling another product for uses that have not been specifically approved.

In a letter to the company, the FDA wrote that DePuy is marketing its Corail Hip System for two unapproved uses, and promoting those uses in an online brochure.

The agency also stated that it never approved the TruMatch Personalized Solution System. It uses software and high-tech CT scanning technology to create a detailed, 3-D view of a patient's knee so a surgeon can properly position a knee implant.

The FDA has told DePuy, which is based in Warsaw, Ind., to stop selling the hip system for unapproved uses and to provide information that would be needed for the agency to approve the TruMatch system.

"The FDA will evaluate the information you submit and decide whether your product may be legally marketed," stated the letter.

In a statement, DePuy said it is "reviewing the letter to understand the FDA's concerns and will respond to their request for information."

The FDA's warning letter, addressed to DePuy President David Floyd, was posted on the agency's website on Tuesday. The letter is dated Aug. 19. It is signed by Timothy A. Ulatowski, director of the Office of Compliance in the FDA center that oversees medical devices.

It states that the Corail Hip System is approved for total hip replacement in patients with six specific types of damage to the hip. But a brochure on DePuy website claims the system can be used for treating two other conditions, according to the FDA.

On Monday, Johnson & Johnson issued its ninth product recall in a year, this one covering millions of 1 Day Acuvue TruEye contact lenses sold in Japan and two dozen other countries in Asia and Europe. The recall followed complaints from customers in Japan of an unusual stinging or pain when inserting the lenses. Johnson & Johnson's Vision Care Inc. business blamed the failure of manufacturing equipment that rinses off substances used in producing the lenses.

Johnson & Johnson already is under scrutiny by officials, Congress and federal prosecutors over eight previous U.S. recalls of nonprescription medicines since last September. Those included millions of bottles of Tylenol, other pain relievers and cold medicines for children and adults.

The recalls have involved problems ranging from bacterial contamination and a nauseating smell on containers to drugs that may have the wrong amount of active ingredient and liquid medicines that may contain tiny metal shavings.

In midday trading, Johnson & Johnson shares fell 78 cents to $58.08, while health-care stocks and the broader markets were all down.

Johnson & Johnson is based in New Brunswick, N.J.

Explore further: Bristol-Myers: FDA blocks hepatitis C drug for now

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Johnson&Johnson expands Tylenol recall

Jan 15, 2010

(AP) -- Johnson & Johnson expanded a recall of over-the-counter medications Friday, the second time it has done so in less than a month because of a moldy smell that has made users sick.

FDA found bacteria in lots for recalled Tylenol

May 04, 2010

(AP) -- Ingredients used by Johnson & Johnson in some of the 40 varieties of children's cold medicines recalled last Friday were contaminated with bacteria, according to a report by the Food and Drug Administration.

New warning OK'd for birth control patch

Jan 21, 2008

The U.S. Food and Drug Administration has approved a warning for the Ortho Evra Contraceptive Transdermal Patch label concerning the risk of blood clots.

FDA approves new breast cancer lab test

Jul 17, 2007

The U.S. Food and Drug Administration has approved the first molecular-based laboratory test for detecting whether breast cancer has metastasized.

J&J recalls infants', children's liquid Tylenol

Sep 25, 2009

(AP) -- Johnson & Johnson's McNeil unit said Thursday it is voluntarily recalling 57 lots of infants' and children's liquid Tylenol products because of possible bacterial contamination.

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

Nov 26, 2014

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.